Primary Site >> Esophagus Cancer
Gene >> SMUG1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Application of whole-body positron emission tomography in the imaging of esophageal cancer: report of a case. PMID: 7640457 |
Ref: FDG-PET in Esophageal Cancer. Incremental Value over Computed Tomography. PMID: 14516649 |
Ref: Imaging features of primary and recurrent esophageal cancer at FDG PET. PMID: 10835124 Ref: Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. PMID: 10986052 |
Ref: Lesion detectability of a gamma camera based coincidence system with FDG in patients with malignant tumors: a comparison with dedicated positron emission tomography. PMID: 15195760 Ref: Neoplasms of the esophagus and stomach. PMID: 15202101 Ref: Imaging of esophageal and gastric cancer. PMID: 15297944 Ref: Imaging for esophageal tumors. PMID: 15382309 Ref: Positron emission tomography/computerized tomography functional imaging of esophageal and colorectal cancer. PMID: 15383205 |
Ref: Comparison of 18F-FLT PET and 18F-FDG PET in esophageal cancer. PMID: 15750150 Ref: PET detection of solitary distant skeletal muscle metastasis of esophageal adenocarcinoma. PMID: 15827406 Ref: The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy. PMID: 15942562 Ref: [Impact of computed tomography (CT) and 18F-deoxyglucose positron emission tomography (FDG-PET) image fusion for conformal radiotherapy in esophageal carcinoma]. PMID: 16023043 Ref: PET/CT in oncology: a major technology for cancer care. PMID: 16086542 Ref: Intense esophageal FDG activity caused by Candida infection obscured the concurrent primary esophageal cancer on PET imaging. PMID: 16166848 Ref: Impact of CT and 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma. PMID: 16168829 |
Ref: The importance of PET in the diagnosis and response evaluation of esophageal cancer. PMID: 17069585 |
Ref: [18F-FDG-PET in therapy response of esophageal cancer]. PMID: 17225182 Ref: [Recommendations for clinical practice: use of TEP-FDG in cancer of the esophagus, stomach, colon and rectum, anal canal, large intestine, pancreas and bile ducts, liver and endocrine tumors (digestive system)]. PMID: 17338096 |
Ref: FDG PET for esophageal cancer complicated by sarcoidosis mimicking mediastinal and hilar lymph node metastases: two case reports. PMID: 18356663 |
Ref: Correlations between selected tumor markers and fluorodeoxyglucose maximal standardized uptake values in esophageal cancer. PMID: 19136271 Ref: Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions. PMID: 19340526 Ref: Prognostic significance of SUV on PET/CT in patients with esophageal cancer: a systematic review and meta-analysis. PMID: 19352191 Ref: Dual-time F-18 FDG-PET/CT imaging for diagnosis of occult non-Hodgkin lymphoma in a patient with esophageal cancer. PMID: 19352282 Ref: The clinical application of (18)F-fluorodeoxyglucose positron emission tomography to predict survival in patients with operable esophageal cancer. PMID: 19472406 Ref: [The role and limitations of FDG-PET in head and neck cancer]. PMID: 20009454 Ref: [A case of effective photodynamic therapy for local recurrence after definitive chemoradiotherapy for esophageal cancer]. PMID: 20037321 |
Ref: Clinical applications of positron emission tomography-computed tomography in oncology. PMID: 20448371 Ref: [Successful treatment of advanced esophageal cancer with lymph node metastases by docetaxel, cisplatin and 5-FU followed by salvage lymphadenectomy--a case report]. PMID: 21224580 |
Ref: Positive correlations between tumor uptake on FDG PET and energy expenditure of patients with esophageal cancer. PMID: 21174177 Ref: [A case of residual metastatic lymph node lesion following definitive chemoradiotherapy for T4 esophageal cancer, successfully treated by outpatient clinic-based sequential chemotherapy with docetaxel followed by S-1]. PMID: 22202394 Ref: Role of F18-FDG PET/CT in the Staging and Restaging of Esophageal Cancer: A Comparison with CECT. PMID: 23204793 |
Ref: The role of qualitative and quantitative analysis of F18-FDG positron emission tomography in predicting pathologic response following chemoradiotherapy in patients with esophageal carcinoma. PMID: 22777832 Ref: Confirmation of histology of PET positive lymph nodes recovered by hand-video-assisted thoracoscopy surgery. PMID: 22909799 Ref: (18)F-FDG PET-detected synchronous primary neoplasms in the staging of esophageal cancer: incidence, cost, and impact on management. PMID: 23154472 Ref: Prognostic value of metabolic volume measured by F-18 FDG PET-CT in patients with esophageal cancer. PMID: 28920313 |
Ref: Proton therapy radiation pneumonitis local dose-response in esophagus cancer patients. PMID: 23127772 Ref: Increased FDG activity in a dermatofibroma in esophageal cancer patient. PMID: 23357820 Ref: Genetic variants in DNA repair pathway genes and risk of esophageal squamous cell carcinoma and gastric adenocarcinoma in a Chinese population. PMID: 23504502 Ref: Limitation of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography (FDG-PET) to detect early synchronous primary cancers in patients with untreated head and neck squamous cell cancer. PMID: 23979967 Ref: [Utility and drawbacks of fludeoxyglucose-positron emission tomography in locally advanced esophageal cancer treated by neoadjuvant chemotherapy followed by esophagectomy]. PMID: 24394040 |
Ref: Maximum standardized uptake value on PET/CT in preoperative assessment of lymph node metastasis from thoracic esophageal squamous cell carcinoma. PMID: 24559853 Ref: Maximum standardized uptake value in (18)F-fluoro-2-deoxyglucose positron emission tomography is associated with advanced tumor factors in esophageal cancer. PMID: 24649354 Ref: Radiation-induced liver disease as a mimic of liver metastases at serial PET/CT during neoadjuvant chemoradiation of distal esophageal cancer. PMID: 24668312 Ref: Prognostic value of baseline FDG uptake on PET-CT in esophageal carcinoma. PMID: 24834144 Ref: Imaging and clinicopathologic features of esophageal gastrointestinal stromal tumors. PMID: 25055264 Ref: Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role? PMID: 25157774 |
Ref: Isolated nasal tip metastasis from esophageal squamous cell carcinoma. PMID: 24566414 Ref: Advantages of FDG-PET/CT over CT alone in the preoperative assessment of lymph node metastasis in patients with esophageal cancer. PMID: 24969050 Ref: Factors that affect PERCIST-defined test-retest comparability: an exploration of feasibility in routine clinical practice. PMID: 26222536 Ref: Pre-Chemoradiotherapy FDG PET/CT cannot Identify Residual Metabolically-Active Volumes within Individual Esophageal Tumors. PMID: 26594591 Ref: Does Metastatic Lymph Node SUVmax Predict Survival in Patients with Esophageal Cancer? PMID: 27529887 |
Ref: Use of FDG-PET to detect a chronic odontogenic infection as a possible source of the brain abscess. PMID: 26497357 Ref: Use of registration-based contour propagation in texture analysis for esophageal cancer pathologic response prediction. PMID: 26738433 Ref: Restaging oesophageal cancer after neoadjuvant therapy with (18)F-FDG PET-CT: identifying interval metastases and predicting incurable disease at surgery. PMID: 26883329 Ref: Potential impact of (18)FDG-PET/CT on surgical approach for operable squamous cell cancer of middle-to-lower esophagus. PMID: 26955283 Ref: A Dirichlet process mixture model for automatic (18)F-FDG PET image segmentation: Validation study on phantoms and on lung and esophageal lesions. PMID: 27147360 Ref: Development of a novel handheld intra-operative laparoscopic Compton camera for (18)F-Fluoro-2-deoxy-2-D-glucose-guided surgery. PMID: 27427184 Ref: 68Ga-NODAGA-RGDyK PET/CT Imaging in Esophageal Cancer: First-in-Human Imaging. PMID: 27607174 Ref: Distribution of FDG-avid nodes in esophageal cancer: implications for radiotherapy target delineation. PMID: 27887643 |
Ref: Adaptive region-growing with maximum curvature strategy for tumor segmentation in (18)F-FDG PET. PMID: 28604372 Ref: Ambiguity of Whole Body PET CT Scans in Diagnosis of Co-existing Tuberculosis and Malignancy: Is Histopathological Confirmation Mandatory? PMID: 29019325 Ref: Present and future roles of FDG-PET/CT imaging in the management of gastrointestinal cancer: an update. PMID: 29238109 |
Ref: Pilot study of serial FLT and FDG-PET/CT imaging to monitor response to neoadjuvant chemoradiotherapy of esophageal adenocarcinoma: correlation with histopathologic response. PMID: 29332233 Ref: A black adrenal adenoma with high FDG uptake on PET/CT scan in a patient with esophageal carcinoma: A case report. PMID: 29499515 Ref: Active Bone Marrow With Focal FDG Accumulation Mimicking Bone Metastasis With a Case of Early Esophageal Cancer. PMID: 29504964 Ref: Total FDG lesion number on PET/CT predicts survival of esophageal carcinoma patients with recurrence following curative surgery. PMID: 29697218 Ref: Esophageal cancer associated with a sarcoid-like reaction and systemic sarcoidosis in lymph nodes: supportive findings of [18F]-fluorodeoxyglucose positron emission tomography-computed tomography during neoadjuvant therapy. PMID: 29943286 Ref: The Importance of Concurrent Chemotherapy for T1 Esophageal Cancer: Role of FDG-PET/CT for Local Control. PMID: 30150456 Ref: Pediatric Esophageal Squamous Cell Carcinoma Staged With 18F-FDG PET/CT. PMID: 30325821 |